The global market for Foot and Mouth Disease (FMD) Vaccines for Pig was valued at US$ 223 million in the year 2024 and is projected to reach a revised size of US$ 436 million by 2031, growing at a CAGR of 10.2% during the forecast period.
Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.
The Foot and Mouth Disease (FMD) vaccines market is driven by the ongoing efforts to control and prevent the spread of this highly contagious viral disease among livestock. FMD vaccines are crucial tools used to protect animals from infection and curb disease outbreaks in the agricultural industry. The rise in the global demand for animal protein and the need for food security contribute to market growth as preventing FMD ensures the health and productivity of livestock populations. Moreover, advancements in vaccine development and the adoption of vaccination programs in high-risk regions have improved disease management. However, the market also faces challenges, including the diversity of FMD virus strains and the need for continuous vaccine updates to match circulating strains. Additionally, addressing regulatory approvals and ensuring vaccine efficacy in different livestock species can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer effective and broad-spectrum FMD vaccines, collaborate with veterinary authorities to implement vaccination strategies, and address the challenges to meet the increasing demand for reliable and efficient FMD prevention solutions in the livestock industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Foot and Mouth Disease (FMD) Vaccines for Pig, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Foot and Mouth Disease (FMD) Vaccines for Pig.
The Foot and Mouth Disease (FMD) Vaccines for Pig market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Foot and Mouth Disease (FMD) Vaccines for Pig market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Foot and Mouth Disease (FMD) Vaccines for Pig manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
BIGVET Biotech
Biogenesis Bag贸
Indian Immunologicals
Boehringer Ingelheim
MSD Animal Health
CEVA
Bayer HealthCare
VECOL
Brilliant Bio Pharma
VETAL
BVI
LIMOR
ME VAC
Agrovet
Segment by Type
Synthetic Peptide Vaccine
Inactivated Vaccine
Segment by Application
Emergency Vaccines
Conventional Vaccines
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines for Pig manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Foot and Mouth Disease (FMD) Vaccines for Pig in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Overview
1.1 Product Definition
1.2 Foot and Mouth Disease (FMD) Vaccines for Pig by Type
1.2.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Synthetic Peptide Vaccine
1.2.3 Inactivated Vaccine
1.3 Foot and Mouth Disease (FMD) Vaccines for Pig by Application
1.3.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Emergency Vaccines
1.3.3 Conventional Vaccines
1.4 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue 2020-2031
1.4.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales 2020-2031
1.4.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Competition by Manufacturers
2.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Foot and Mouth Disease (FMD) Vaccines for Pig, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines for Pig, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines for Pig, Product Type & Application
2.7 Global Key Manufacturers of Foot and Mouth Disease (FMD) Vaccines for Pig, Date of Enter into This Industry
2.8 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Competitive Situation and Trends
2.8.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Foot and Mouth Disease (FMD) Vaccines for Pig Players 麻豆原创 Share by Revenue
2.8.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Scenario by Region
3.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Region: 2020-2031
3.2.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Region: 2020-2025
3.2.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Region: 2026-2031
3.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Region: 2020-2031
3.3.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Region: 2020-2025
3.3.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Region: 2026-2031
3.4 North America Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Facts & Figures by Country
3.4.1 North America Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Country (2020-2031)
3.4.3 North America Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Facts & Figures by Country
3.5.1 Europe Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Country (2020-2031)
3.5.3 Europe Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Region (2020-2031)
3.6.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Country (2020-2031)
3.7.3 Latin America Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Country (2020-2031)
3.8.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Type (2020-2031)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Type (2020-2025)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Type (2026-2031)
4.1.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Type (2020-2031)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Type (2020-2025)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Type (2026-2031)
4.2.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Price by Type (2020-2031)
5 Segment by Application
5.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Application (2020-2031)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Application (2020-2025)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales by Application (2026-2031)
5.1.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Application (2020-2031)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Application (2020-2025)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue by Application (2026-2031)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Foot and Mouth Disease (FMD) Vaccines for Pig Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jinyu Group
6.1.1 Jinyu Group Company Information
6.1.2 Jinyu Group Description and Business Overview
6.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.1.5 Jinyu Group Recent Developments/Updates
6.2 Cavet Bio
6.2.1 Cavet Bio Company Information
6.2.2 Cavet Bio Description and Business Overview
6.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.2.5 Cavet Bio Recent Developments/Updates
6.3 CAHIC
6.3.1 CAHIC Company Information
6.3.2 CAHIC Description and Business Overview
6.3.3 CAHIC Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CAHIC Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.3.5 CAHIC Recent Developments/Updates
6.4 Tecon Group
6.4.1 Tecon Group Company Information
6.4.2 Tecon Group Description and Business Overview
6.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.4.5 Tecon Group Recent Developments/Updates
6.5 Shen Lian
6.5.1 Shen Lian Company Information
6.5.2 Shen Lian Description and Business Overview
6.5.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.5.5 Shen Lian Recent Developments/Updates
6.6 BIGVET Biotech
6.6.1 BIGVET Biotech Company Information
6.6.2 BIGVET Biotech Description and Business Overview
6.6.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.6.5 BIGVET Biotech Recent Developments/Updates
6.7 Biogenesis Bag贸
6.7.1 Biogenesis Bag贸 Company Information
6.7.2 Biogenesis Bag贸 Description and Business Overview
6.7.3 Biogenesis Bag贸 Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biogenesis Bag贸 Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.7.5 Biogenesis Bag贸 Recent Developments/Updates
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Company Information
6.8.2 Indian Immunologicals Description and Business Overview
6.8.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.8.5 Indian Immunologicals Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Company Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 MSD Animal Health
6.10.1 MSD Animal Health Company Information
6.10.2 MSD Animal Health Description and Business Overview
6.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.10.5 MSD Animal Health Recent Developments/Updates
6.11 CEVA
6.11.1 CEVA Company Information
6.11.2 CEVA Description and Business Overview
6.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.11.5 CEVA Recent Developments/Updates
6.12 Bayer HealthCare
6.12.1 Bayer HealthCare Company Information
6.12.2 Bayer HealthCare Description and Business Overview
6.12.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.12.5 Bayer HealthCare Recent Developments/Updates
6.13 VECOL
6.13.1 VECOL Company Information
6.13.2 VECOL Description and Business Overview
6.13.3 VECOL Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.13.4 VECOL Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.13.5 VECOL Recent Developments/Updates
6.14 Brilliant Bio Pharma
6.14.1 Brilliant Bio Pharma Company Information
6.14.2 Brilliant Bio Pharma Description and Business Overview
6.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.14.5 Brilliant Bio Pharma Recent Developments/Updates
6.15 VETAL
6.15.1 VETAL Company Information
6.15.2 VETAL Description and Business Overview
6.15.3 VETAL Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.15.4 VETAL Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.15.5 VETAL Recent Developments/Updates
6.16 BVI
6.16.1 BVI Company Information
6.16.2 BVI Description and Business Overview
6.16.3 BVI Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.16.4 BVI Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.16.5 BVI Recent Developments/Updates
6.17 LIMOR
6.17.1 LIMOR Company Information
6.17.2 LIMOR Description and Business Overview
6.17.3 LIMOR Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.17.4 LIMOR Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.17.5 LIMOR Recent Developments/Updates
6.18 ME VAC
6.18.1 ME VAC Company Information
6.18.2 ME VAC Description and Business Overview
6.18.3 ME VAC Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.18.4 ME VAC Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.18.5 ME VAC Recent Developments/Updates
6.19 Agrovet
6.19.1 Agrovet Company Information
6.19.2 Agrovet Description and Business Overview
6.19.3 Agrovet Foot and Mouth Disease (FMD) Vaccines for Pig Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Agrovet Foot and Mouth Disease (FMD) Vaccines for Pig Product Portfolio
6.19.5 Agrovet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Foot and Mouth Disease (FMD) Vaccines for Pig Industry Chain Analysis
7.2 Foot and Mouth Disease (FMD) Vaccines for Pig Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Foot and Mouth Disease (FMD) Vaccines for Pig Production Mode & Process Analysis
7.4 Foot and Mouth Disease (FMD) Vaccines for Pig Sales and 麻豆原创ing
7.4.1 Foot and Mouth Disease (FMD) Vaccines for Pig Sales Channels
7.4.2 Foot and Mouth Disease (FMD) Vaccines for Pig Distributors
7.5 Foot and Mouth Disease (FMD) Vaccines for Pig Customer Analysis
8 Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Dynamics
8.1 Foot and Mouth Disease (FMD) Vaccines for Pig Industry Trends
8.2 Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Drivers
8.3 Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Challenges
8.4 Foot and Mouth Disease (FMD) Vaccines for Pig 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
BIGVET Biotech
Biogenesis Bag贸
Indian Immunologicals
Boehringer Ingelheim
MSD Animal Health
CEVA
Bayer HealthCare
VECOL
Brilliant Bio Pharma
VETAL
BVI
LIMOR
ME VAC
Agrovet
听
听
*If Applicable.